PreciseDx is a healthcare technology company that utilizes its proprietary AI platform, OncoIntelligence™, to provide rapid and accurate breast cancer risk stratification through its product, PreciseBreast®
PreciseDx is a healthcare technology company that utilizes its proprietary AI platform, OncoIntelligence™, to provide rapid and accurate breast cancer risk stratification through its product, PreciseBreast®. The platform analyzes cellular morphology of tissue samples to deliver objective results in hours, improving patient care and decision-making for oncologists and pathologists.